Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when PRVA files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsPrivia Health appoints healthcare executive Dr. Opella Ernest to Board
Filed August 18, 2026 · Period ending August 12, 2026 · ~1 min read
Key Changes
-
medium
Dr. Opella Ernest elected as Class III independent director and Compliance Committee member, effective September 1, 2026. She brings 20+ years of healthcare executive experience, currently serving as President of HCSC Markets at Health Care Service Corporation.
Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation verify on EDGAR → -
low
Dr. Ernest will receive standard non-employee director compensation: annual cash retainer plus annual equity grants of restricted stock units valued at $200,000, with initial grant pro-rated through next annual meeting.
Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation verify on EDGAR →
Summary
Privia Health expanded its Board of Directors with the appointment of Dr. Opella Ernest, effective September 1, 2026. Dr. Ernest is an independent director under Nasdaq rules and will serve on the Compliance Committee. She currently leads HCSC Markets at Health Care Service Corporation, overseeing strategic direction, clinical operations, and growth across all market segments—a role she has held since 2023.
Prior to that, she served as Executive Vice President and Chief Operating Officer at HCSC from 2021 to 2023, where she focused on transforming customer and provider experiences through technology and innovation. For retail holders, this is a routine governance matter with no immediate impact on operations or strategy. Dr.
Ernest's background in healthcare operations and technology aligns with Privia's physician enablement platform, potentially strengthening board oversight as the company scales. Her compensation follows the standard director program with no special arrangements.
Section-by-Section Diff
Event · Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation
Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation filed; see Key Changes for terms.
Added in current filing · verify on EDGAR →
On August 12, 2026, the Board of Directors (the “Board”) of Privia Health Group, Inc. (the “Company”) elected Opella Ernest, M.D. to the Board as a Class III director, effective September 1, 2026. The Board also appointed Dr. Ernest as a member of the Compliance Committee of the Board effective September 1, 2026.
The Board elected Dr. Opella Ernest as a new Class III director and appointed her to the Compliance Committee, both effective September 1, 2026. The Board determined Dr. Ernest to be independent under Nasdaq rules, with no related-party transactions or special arrangements involved in her selection.
Event · Exhibit 99.1
Added in current filing · view on EDGAR →
Privia Health Group, Inc. (Nasdaq: PRVA) announced the appointment of Opella Ernest, M.D. to its Board of Directors, effective September 1, 2026. She has also been named a member of the Compliance Committee of the Board.
Privia Health appointed Dr. Opella Ernest to its Board of Directors effective September 1, 2026, and named her to the Compliance Committee. Dr. Ernest brings over 20 years of healthcare executive experience, currently serving as President, HCSC Markets at Health Care Service Corporation since 2023, where she oversees strategic direction, clinical operations, and growth for all market segments.
Added in current filing · view on EDGAR →
Dr. Ernest has over 20 years of healthcare executive experience. Since 2023, she has served as President, HCSC Markets at Health Care Service Corporation, responsible for the strategic direction, clinical operations, performance, and growth for all market segments. She served as Executive Vice President, Chief Operating Officer at HCSC from 2021 to 2023, transforming HCSC’s customer and provider experience through advancements in technology and innovation.
Dr. Ernest has extensive healthcare leadership experience, including her current role as President of HCSC Markets at Health Care Service Corporation since 2023 and prior role as Executive Vice President and Chief Operating Officer from 2021 to 2023. Her background includes transforming customer and provider experiences through technology and innovation, which aligns with Privia's physician enablement and technology platform strategy.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Aug 19, 2026 · How we verify